Study Principal Investigator: Felix Böhm, MD, PhD
Department of Cardiology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.

Study Co-investigator: Andreas Rück, MD, PhD
Department of Cardiology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.

Study Chair: Stefan James, MD, Professor
Department of Medical Sciences, Uppsala University, Sweden.

 

Sponsor: Karolinska University Hospital, Stockholm, Sweden.

Steering committee: One investigator from each site will be represented.

Participating sites: Click on the flags on the Starting page.

 

National coordinators

Sweden: Andreas Rück, Karolinska

Norway: Eigil Fossum, OUS Ullevål, Oslo

Denmark: Thomas Engstrøm, Rigshospitalet, Copenhagen

Iceland: Thorarinn Gudnasson, Reykjavik

Finland: Mika Laine, Helsinki University Hospital

Latvia: Andrejs Erglis, Riga

Lithuania: Andrej Pileckij, Klaipeda

Australia: Carl Schultz, Perth

UK - Scotland: Colin Berry, (UK Chief Investigator)

UK - England: Anthony Gershlick, (UK Co-Chief Investigator)

Serbia: Goran Stankovic, Belgrade

Germany: Christoph Liebtrau, Bad Nauheim

New Zealand: Madhav Menon, Hamilton

 

FULL REVASC Study team

Uppsala Clinical Research Center (UCR), Uppsala, Sweden:

Project managers: Ulla Nässander Schikan, fullrevasc@ucr.uu.se

Susanne Johansson, fullrevasc@ucr.uu.se

Monitors:  Åsa Michelgård Palmquist, fullrevasc@ucr.uu.se

Caroline Moberg, fullrevasc@ucr.uu.se           

Admin: Susanna Thörnqvist, fullrevasc.admin@ucr.uu.se 

Data manager: Åsa Eck

Statistician: Ollie Östlund

Clinical Events Adjudication: Kai Eggers

Health economist: Sophie Langenskiöld, Uppsala University


DSMB: Nico Pijls (The Netherlands), Bernard De Bruyne (Belgium), Nils Johnson (USA), William F Fearon (USA).